Palchaudhuri; Rahul
Patent Applications and Registrations
Patent applications and USPTO patent grants for Palchaudhuri; Rahul.The latest application filed is for "anti-cd45 antibodies and conjugates thereof".
Company Profile
17.13.31
- Palchaudhuri; Rahul - Somerville MA
- Palchaudhuri; Rahul - Cambridge MA
- Palchaudhuri; Rahul - Champaign IL
Patent Activity
| Patent | Date |
|---|---|
| Anti-cd45 Antibodies And Conjugates Thereof App 20220267441 - Boitano; Anthony ; et al. | 2022-08-25 |
| Anti-CD45 Antibody Drug Conjugates and Uses Thereof App 20220175951 - Boitano; Anthony ; et al. | 2022-06-09 |
| Anti-cd117 Antibodies And Uses Thereof App 20220177575 - Palchaudhuri; Rahul ; et al. | 2022-06-09 |
| Anti-cd117 Antibodies And Uses Thereof App 20220177578 - Palchaudhuri; Rahul ; et al. | 2022-06-09 |
| Conditioning Methods For Gene Therapy App 20220175946 - BOITANO; Anthony ; et al. | 2022-06-09 |
| Compositions And Methods For Non-myeloablative Conditioning App 20210388094 - Scadden; David T. ; et al. | 2021-12-16 |
| Methods For Allogeneic Hematopoietic Stem Cell Transplantation App 20210379195 - Palchaudhuri; Rahul ; et al. | 2021-12-09 |
| Compositions And Methods For The Depletion Of Cd5+ Cells App 20210369854 - Boitano; Anthony ; et al. | 2021-12-02 |
| Anti-cd45 Antibodies And Conjugates Thereof App 20210371524 - Palchaudhuri; Rahul ; et al. | 2021-12-02 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20210317228 - Pearse; Bradley R. ; et al. | 2021-10-14 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20210206872 - Pearse; Bradley R. ; et al. | 2021-07-08 |
| Compositions and methods for non-myeloablative conditioning Grant 10,906,980 - Scadden , et al. February 2, 2 | 2021-02-02 |
| Compositions and methods for the depletion of CD117+ cells Grant 10,899,843 - Pearse , et al. January 26, 2 | 2021-01-26 |
| Compositions and methods for the depletion of CD117+ cells Grant 10,882,915 - Pearse , et al. January 5, 2 | 2021-01-05 |
| Fc Silenced Antibody Drug Conjugates (adcs) And Uses Thereof App 20200376135 - Boitano; Anthony ; et al. | 2020-12-03 |
| Compositions And Methods For The Depletion Of Cd2+ Cells App 20200368363 - BOITANO; Anthony ; et al. | 2020-11-26 |
| Compositions And Methods For The Depletion Of Cd137+ Cells App 20200289664 - Hartigan; Adam ; et al. | 2020-09-17 |
| Compositions And Methods For The Depletion Of Cd5+ Cells App 20200276326 - Boitano; Anthony ; et al. | 2020-09-03 |
| Fc Silenced Antibody Drug Conjugates (adcs) And Uses Thereof App 20200255523 - Kind Code | 2020-08-13 |
| Compositions And Methods For Non-myeloablative Conditioning App 20200148776 - Scadden; David T. ; et al. | 2020-05-14 |
| Compositions and methods for the depletion of CD137+ cells Grant 10,576,161 - Hartigan , et al. | 2020-03-03 |
| Compositions and methods for non-myeloablative conditioning Grant 10,570,207 - Scadden , et al. Feb | 2020-02-25 |
| Compositions And Methods For Non-myeloablative Conditioning App 20200040093 - Scadden; David T. ; et al. | 2020-02-06 |
| Compositions and methods for the depletion of CD137+ cells Grant 10,434,185 - Hartigan , et al. O | 2019-10-08 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20190153114 - Pearse; Bradley R. ; et al. | 2019-05-23 |
| Compositions And Methods For The Depletion Of Cd117+ Cells App 20190144558 - Pearse; Bradley R. ; et al. | 2019-05-16 |
| Compounds and anti-tumor NQO1 substrates Grant 10,285,986 - Hergenrother , et al. | 2019-05-14 |
| Compositions and methods for non-myeloablative conditioning Grant 10,280,225 - Scadden , et al. | 2019-05-07 |
| Compositions And Methods For Non-myeloablative Conditioning App 20190100593 - Scadden; David T. ; et al. | 2019-04-04 |
| Compositions And Methods For The Depletion Of Cd137+ Cells App 20190076548 - Hartigan; Adam ; et al. | 2019-03-14 |
| Compositions And Methods For The Depletion Of Cd137+ Cells App 20180289832 - Hartigan; Adam ; et al. | 2018-10-11 |
| Compounds And Anti-tumor Nqo1 Substrates App 20180207150 - HERGENROTHER; Paul J. ; et al. | 2018-07-26 |
| Compounds and anti-tumor NQO1 substrates Grant 9,925,180 - Hergenrother , et al. March 27, 2 | 2018-03-27 |
| Compounds And Anti-tumor Nqo1 Substrates App 20170182030 - HERGENROTHER; Paul J. ; et al. | 2017-06-29 |
| Small Molecules That Induce Intrinsic Pathways Apoptosis App 20170105963 - HERGENROTHER; Paul J. ; et al. | 2017-04-20 |
| Compounds and anti-tumor NQO1 substrates Grant 9,611,266 - Hergenrother , et al. April 4, 2 | 2017-04-04 |
| Compositions And Methods For Non-myeloablative Conditioning App 20160324982 - Scadden; David T. ; et al. | 2016-11-10 |
| Homeodomain Fusion Proteins And Uses Thereof App 20160122405 - Palchaudhuri; Rahul ; et al. | 2016-05-05 |
| Compounds And Anti-tumor Nqo1 Substrates App 20160122348 - Hergenrother; Paul J. ; et al. | 2016-05-05 |
| Compounds and anti-tumor NQO1 substrates Grant 9,233,960 - Hergenrother , et al. January 12, 2 | 2016-01-12 |
| Compounds And Anti-tumor Nqo1 Substrates App 20150011509 - Hergenrother; Paul J. ; et al. | 2015-01-08 |
| Phosphorous containing compounds including triphenylmethylphosphonate esters for the treatment of melanoma and other cancers Grant 7,709,465 - Hergenrother , et al. May 4, 2 | 2010-05-04 |
| Phosphorous Containing Compounds Including Triphenylmethylphosphonate Esters for the Treatment of Melanoma and Other Cancers App 20090004293 - Hergenrother; Paul J. ; et al. | 2009-01-01 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 